Salidroside alleviates ferroptosis in FAC-induced Age-related macular degeneration models by activating

Meijiang Zhu1, Jing Yu1

  • 1Tongji University School of Medicine, Shanghai Tenth People's Hospital, Shanghai, China.

PubMed
Abstract

Insights

Ferroptosis contributes to dry age-related macular degeneration (AMD). Salidroside protects against ferroptosis by activating the Nrf2/SLC7A11/GPX4 pathway, offering a potential therapeutic strategy for dry AMD.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Pharmacology

Background:

  • Dry age-related macular degeneration (AMD) causes irreversible vision loss.
  • Ferroptosis, a cell death pathway involving iron and lipid peroxidation, is implicated in dry AMD pathogenesis.
  • Salidroside, a natural compound, possesses antioxidant and anti-inflammatory properties.

Purpose of the Study:

  • To investigate the role of ferroptosis in dry AMD.
  • To explore the protective mechanisms of salidroside against ferroptosis in dry AMD models.

Main Methods:

  • ARPE-19 cells and C57BL/6 mice models were used.
  • Ferroptosis was induced using ferrous ammonium citrate (FAC).
  • Salidroside treatment and Nrf2 gene silencing were performed. Biomarkers were analyzed via western blotting, immunofluorescence, and flow cytometry.

Main Results:

  • FAC induced ferroptosis in ARPE-19 cells and RPE cells in mice, evidenced by decreased viability, mitochondrial potential, and altered ferroptosis markers.
  • Salidroside treatment reversed these effects by upregulating Nrf2, SLC7A11, and GPX4.
  • Nrf2 silencing diminished salidroside's protective effects.

Conclusions:

  • Ferrous ammonium citrate induces ferroptosis in retinal pigment epithelium (RPE) cells, contributing to dry AMD.
  • Salidroside demonstrates therapeutic potential for dry AMD by activating the Nrf2/SLC7A11/GPX4 signaling pathway.